| Product NDC: | 50201-0421 |
| Proprietary Name: | BROMO SELTZER |
| Non Proprietary Name: | ASPIRIN, SODIUM BICARBONATE, CITRIC ACID |
| Active Ingredient(s): | 1000; 325; 1916 mg/1; mg/1; mg/1 & nbsp; ASPIRIN, SODIUM BICARBONATE, CITRIC ACID |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EFFERVESCENT |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 50201-0421 |
| Labeler Name: | Tower Laboratories Ltd |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part343 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20121001 |
| Package NDC: | 50201-0421-2 |
| Package Description: | 20 TABLET, EFFERVESCENT in 1 CARTON (50201-0421-2) |
| NDC Code | 50201-0421-2 |
| Proprietary Name | BROMO SELTZER |
| Package Description | 20 TABLET, EFFERVESCENT in 1 CARTON (50201-0421-2) |
| Product NDC | 50201-0421 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | ASPIRIN, SODIUM BICARBONATE, CITRIC ACID |
| Dosage Form Name | TABLET, EFFERVESCENT |
| Route Name | ORAL |
| Start Marketing Date | 20121001 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Tower Laboratories Ltd |
| Substance Name | ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE |
| Strength Number | 1000; 325; 1916 |
| Strength Unit | mg/1; mg/1; mg/1 |
| Pharmaceutical Classes |